02/06/2025
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 424B4 | |
01/27/2025
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
01/15/2025
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
01/08/2025
3:11 PM | Panis Jaydriane (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
3:47 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/30/2024
3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:15 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
4:29 PM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for VRPX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/29/2024
5:39 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
4:01 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
5:06 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:20 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
11/07/2024
4:01 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/28/2024
3:08 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/18/2024
4:28 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/10/2024
4:07 PM | Virpax Pharmaceuticals (Filer)
| Form 10-K/A | |
10/10/2024
4:08 PM | Virpax Pharmaceuticals (Filer)
| Form 10-K/A | |
10/09/2024
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K/A | |
10/04/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:12 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
8:05 AM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
08/13/2024
6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:26 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/26/2024
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
6:45 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
5:40 PM | Su Judy (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/15/2024
7:00 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:09 PM | Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
3:10 PM | Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
11:48 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:00 PM | Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2024
3:01 PM | Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2024
3:02 PM | Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:03 PM | Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
$5,000 DOGE check? (Ad) Elon Musk's DOGE agenda just took a very surprising turn...
Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers.
The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail. Everything you need to know is right here. |
07/08/2024
3:32 PM | Virpax Pharmaceuticals (Filer)
| Form DEFA14A | |
07/08/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
4:09 PM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
06/12/2024
4:11 PM | Virpax Pharmaceuticals (Filer)
| Form ARS | |
05/14/2024
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
05/13/2024
4:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
05/13/2024
3:02 PM | Virpax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
8:54 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/30/2024
6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
04/18/2024
3:17 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/26/2024
7:15 AM | Virpax Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
